Phesgo 1200 mg/600 mg/15 ml, Injektionslösung

7680678280022 CH-67828 Injektionslösung
Phesgo 1200 mg/600 mg/15 ml, Injektionslösung
Phesgo 1200 mg/600 mg/15 ml, Injektionslösung
1 / 2
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
09/12/2024
Summary of Product Characteristics
Français
09/12/2024
Summary of Product Characteristics
Italien
09/12/2024

Detailed composition

Substance Quantity Type Category
(N/A)
1200.0 MG Substance Wirkstoff (Principe actif)
(N/A)
600.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 6217.15
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/07/2022

Authorization holder

Roche Pharma (Schweiz) AG

4058 Basel

Authorization information

Swissmedic authorization number
67828
Drug name
Phesgo, Injektionslösung
Galenic form
LSINJ
ATC Code
L01FY01
Authorization status
Z
Dispensing category
A
First authorization
08/04/2021
Authorization expiration date
31/12/9999
IT Number
07.16.1.
Domain
Human medicine
Field of application
Mammakarzinom

Package details

Description (FR)
PHESGO sol inj 1200 mg/600 mg/15 ml flac
Description (DE)
PHESGO Inj Lös 1200 mg/600 mg/15 ml Durchstf
Market launch
08/04/2021
Narcotic (BTM)
No

Other package sizes (1)

PHESGO sol inj 600 mg/600 mg/10 ml flac
1 DUR
GTIN: 7680678280015
View